New ravidomycin analogues, FE35A and FE35B, apoptosis inducers produced by Streptomyces rochei.
Yamashita
N
N
Institute of Molecular and Cellular Biosciences, The University of Tokyo, Japan.
Shin-ya
K
K
Furihata
K
K
Hayakawa
Y
Y
Seto
H
H
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis / Q000737:chemistry / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3; D020169:Caspases / Q000096:biosynthesis; D004354:Drug Screening Assays, Antitumor; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D013302:Streptomyces / Q000378:metabolism; D020298:U937 Cells
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; C117822:FE 35A; C117823:FE 35B; C038314:ravidomycin; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases